| Kerron Blunte, OT | |
|
2112 F St Nw Ste 305, Washington, DC 20037-2761 | |
| (202) 912-8480 | |
| (202) 912-8484 |
| Full Name | Kerron Blunte |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapy |
| Experience | 13 Years |
| Location | 2112 F St Nw Ste 305, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417225459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT210002137 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centers For Advanced Orthopaedics Llc | 8123260981 | 476 |
News Archive
Cancer stem cells are like zombies — even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more tumors.
Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.
Systech International, innovator of Packaging Execution Systems (PES) for the pharmaceutical industry, today announced the availability of a new software release for its widely-deployed Serialized Product Tracking (SPT) application.
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today.
› Verified 8 days ago
| Provider Name | Centers For Advanced Orthopaedics Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487093167 PECOS PAC ID: 8123260981 Enrollment ID: O20131024001780 |
News Archive
Cancer stem cells are like zombies — even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more tumors.
Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.
Systech International, innovator of Packaging Execution Systems (PES) for the pharmaceutical industry, today announced the availability of a new software release for its widely-deployed Serialized Product Tracking (SPT) application.
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kerron Blunte, OT 2112 F St Nw Ste 305, Washington, DC 20037-2761 Ph: (202) 912-8480 | Kerron Blunte, OT 2112 F St Nw Ste 305, Washington, DC 20037-2761 Ph: (202) 912-8480 |
News Archive
Cancer stem cells are like zombies — even after a tumor is destroyed, they can keep coming back. These cells have an unlimited capacity to regenerate themselves, making more cancer stem cells and more tumors.
Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.
Systech International, innovator of Packaging Execution Systems (PES) for the pharmaceutical industry, today announced the availability of a new software release for its widely-deployed Serialized Product Tracking (SPT) application.
Data showing the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML) are the subject of an advance online publication in the journal Leukemia, ChemGenex Pharmaceuticals Limited (ASX:CXS and NASDAQ:CXSP) announced today.
› Verified 8 days ago
Miss Samora Casimir, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6900 Georgia Ave Nw, Washington, DC 20307 Phone: 443-802-7824 | |
Petra Doyle, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 8th St Ne, Suite 301, Washington, DC 20002 Phone: 202-544-5439 | |
Lisa George, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4400 Jenifer St Nw, Suite 280, Washington, DC 20015 Phone: 202-244-8089 | |
Andrea L. Meehan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 50 Irving St Nw, Washington, DC 20422 Phone: 202-745-8000 | |
Samantha Fulp, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 T St Ne, Washington, DC 20002 Phone: 956-278-0770 | |
Tsegie Kassahun, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1818 Newton St Nw, Washington, DC 20010 Phone: 202-328-7400 | |
Dr. Nikia Brocks, OTD,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2411 32nd St Se, Washington, DC 20020 Phone: 202-575-5404 Fax: 301-576-5404 |